Stock Track | Mesa Laboratories Stock Soars 5.2% on Strong Q3 Results and Upbeat Outlook

Stock Track

2025/02/04

Shares of Mesa Laboratories (MLAB) surged 5.2% in pre-market trading on Tuesday, following the company's impressive third-quarter fiscal 2025 results and upbeat outlook.

The life science tools and quality control solutions provider reported better-than-expected earnings of $2.72 per share, surpassing analysts' estimates by a wide margin. Revenue also came in higher at $62.84 million, beating expectations by nearly 7%.

The strong performance was driven by solid growth across all business segments, particularly in the Biopharmaceutical Development and Calibration Solutions divisions. The company's strategic acquisitions, including GKE, also contributed to the revenue growth.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1153391512"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153391512\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153391512?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-04 22:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153391512","market":"us","top_or_hot":-1,"title":"Stock Track | Mesa Laboratories Stock Soars 5.2% on Strong Q3 Results and Upbeat Outlook","media":"Stock Track","content":"<p>Shares of Mesa Laboratories (MLAB) surged 5.2% in pre-market trading on Tuesday, following the company's impressive third-quarter fiscal 2025 results and upbeat outlook.</p>\n\n<p>The life science tools and quality control solutions provider reported better-than-expected earnings of $2.72 per share, surpassing analysts' estimates by a wide margin. Revenue also came in higher at $62.84 million, beating expectations by nearly 7%.</p>\n\n<p>The strong performance was driven by solid growth across all business segments, particularly in the Biopharmaceutical Development and Calibration Solutions divisions. The company's strategic acquisitions, including GKE, also contributed to the revenue growth.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Mesa Laboratories Stock Soars 5.2% on Strong Q3 Results and Upbeat Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Mesa Laboratories Stock Soars 5.2% on Strong Q3 Results and Upbeat Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-04 22:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Mesa Laboratories (MLAB) surged 5.2% in pre-market trading on Tuesday, following the company's impressive third-quarter fiscal 2025 results and upbeat outlook.</p>\n\n<p>The life science tools and quality control solutions provider reported better-than-expected earnings of $2.72 per share, surpassing analysts' estimates by a wide margin. Revenue also came in higher at $62.84 million, beating expectations by nearly 7%.</p>\n\n<p>The strong performance was driven by solid growth across all business segments, particularly in the Biopharmaceutical Development and Calibration Solutions divisions. The company's strategic acquisitions, including GKE, also contributed to the revenue growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MLAB","symbol_name":"Mesa Laboratories","start_time":0,"source_url":"","article_id":"1153391512","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153391512","pubTimestamp":1738679565,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Mesa Laboratories  surged 5.2% in pre-market trading on Tuesday, following the company's impressive third-quarter fiscal 2025 results and upbeat outlook.The life science tools and quality control solutions provider reported better-than-expected earnings of $2.72 per share, surpassing analysts' estimates by a wide margin. Revenue also came in higher at $62.84 million, beating expectations by nearly 7%.The strong performance was driven by solid growth across all business segments, partic","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MLAB":"Mesa Laboratories"},"translate_title":"股票轨迹Mesa Laboratories股价因强劲的第三季度业绩和乐观的前景而飙升5.2%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MLAB":1},"content_text":"Shares of Mesa Laboratories (MLAB) surged 5.2% in pre-market trading on Tuesday, following the company's impressive third-quarter fiscal 2025 results and upbeat outlook.\nThe life science tools and quality control solutions provider reported better-than-expected earnings of $2.72 per share, surpassing analysts' estimates by a wide margin. Revenue also came in higher at $62.84 million, beating expectations by nearly 7%.\nThe strong performance was driven by solid growth across all business segments, particularly in the Biopharmaceutical Development and Calibration Solutions divisions. The company's strategic acquisitions, including GKE, also contributed to the revenue growth.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}